WORKSHOP: Neurodevelopmental Disorders Past, Present and Future - In a Mental Health Perspective
Presenting Author(s): Dr. Prajjita Bardoloi
Date and time: 23 Mar 2024 from 14:50 to 15:20
Location: Wildrose Salon A/B
Learning Objectives
1. To review historical aspect, current concepts and the future directions in diagnosis and treatment of neurodevelopmental disorder, in a mental health perspective;
2. How can we screen for underlying neurodevelopmental disorders / Intellectual disability/ autism during a regular psychiatric assessment?; and
3. Neurodevelopmental disorder and other psychiatric disorders - a concurrent disorder treatment approach.
Literature References
1. Mullin AP., et al. “Neurodevelopmental disorders: mechanisms and boundary definitions from genomes, interactomes and proteomes”. Translational Psychiatry 3.12 (2013): e329.
2. ICD-11, International Classification of Diseases 11th Revision. The global standard for diagnostic health information (2018).
3. Diagnostic and Statistical Manual of Mental Disorders. 5th ed.: The American Psychiatric Association (APA) (2013).
4. Harris JC. “New terminology for mental retardation in DSM-5 and ICD-11”. Current Opinion in Psychiatry 26.3 (2013): 260-262.
5. Casey BJ., et al. “A Neurodevelopmental Perspective on the Research Domain Criteria (RDoC) Framework”. Biological Psychiatry 76.5 (2014): 350-353.
6. Morris-Rosendahl DJ and Crocq M. “Neurodevelopmental disorders—the history and future of a diagnostic concept”. Dialogues in Clinical Neuroscience 22.1 (2020): 65-72.
7. Gaudet I and Gallagher A. “Description and classification of neurodevelopmental disabilities”. Handbook of Clinical Neurology: Elsevier Health Sciences (2020): 3-6.
8. Wehmeyer M. ‘The Story of Intellectual Disability: An Evolution of Meaning, Understanding, and Public perception”- Book, Baltimore: Paul H. Brookes Publishing Co (2013).
9. Groff CA. “Mental retardation”. New York, NY: MSS Information Corporation (1973).
10. McNabb C. Medieval Disability Sourcebook: Western Europe. Punctum Books (2020).
11. Ivan Brown and John P Radford. “The Growth and Decline of Institutions for People with Developmental Disabilities in Ontario: 1876-2009”. Journal on Developmental Disabilities 21.2 (2015): 7.
12. Children’s Health and the Environment WHO Training Package for the Health Sector World Health Organization. CHILDREN ANDNEURODEVELOPMENTAL BEHAVIOURAL. INTELLECTUAL DISORDERS (NDBID).
13. Vissers Lisenka ELM., et al. “Genetic studies in intellectual disability and related disorders”. Nature Reviews Genetics 17.1 (2015): 9-18.
14. Mitchell KJ. “The Genetic Architecture of Neurodevelopmental Disorders”. The Genetics of Neurodevelopmental Disorders Hoboken, NJ, USA: John Wiley and Sons, Inc (2015): 1-28.
15. Moore KL. “The developing human”. Philadelphia [u.a.]: Saunders (1973).
16. Hendren R and Hagerman R. “Treatment of Neurodevelopmental Disorders: Targeting Neurobiological Mechanisms: Targeting Neurobiological Mechanisms”. Oxford University Press (2014).
17. Rice D., et al. “Critical periods of vulnerability for the developing nervous system: evidence from humans and animal models”. Environmental Health Perspectives 108 (2000): 511-533.
18. Schuengel C., et al. “Impact of Research About the Early Development of Children With Intellectual Disability: A Science Mapping Analysis”. Frontiers in Education (Lausanne) 4 (2019): 1-11.
19. “Diagnosis of Birth Defects”.
20. Bélanger SA and Caron J. “Evaluation of the child with global developmental delay and intellectual disability”. Paediatrics and Child Health 23.6 (2018): 403-410.
21. Wieacker P and Steinhard J. “The prenatal diagnosis of genetic diseases”. Deutsches Ärzteblatt International 107.48 (2010): 857-862.
22. Understanding Genetics: A District of Columbia Guide for Patients and Health Professionals Genetic Alliance, District of Columbia Department of Health Genetic Alliance, Posted in the
Resource Repository (2010).
23. van Karnebeek CD and Stockler-Ipsiroglu S. “Early identification of treatable inborn errors of metabolism in children with intellectual disability: the treatable intellectual disability endeavor protocol in British Columbia”. Paediatrics and Child Health 19.9 (2014): 469-471.
24. Sun F., et al. “Genetic Testing for Developmental Disabilities, Intellectual Disability, and Autism Spectrum Disorder” (2015). 50 Neurodevelopmental Disorders: The Past, Present and the Future Citation: Prajjita Sarma Bardoloi. “Neurodevelopmental Disorders: The Past, Present and the Future". Acta Scientific Neurology 4.2 (2021): 44-50.
25. Shaffer LG. “American College of Medical Genetics guideline on the cytogenetic evaluation of the individual with developmental delay or mental retardation”. Genetics in Medicine 7.9 (2005): 650-654.
26. Moore P. “Autism and Other Neurodevelopmental Disorders”. R.L. Hansen and S.J. Rogers (Eds.) Washington, DC: American Psychiatric Association (2013): 326.
27. Picker JD and Walsh CA. “New innovations: Therapeutic opportunities for intellectual disabilities”. Annals of Neurology 74.3 (2013): 382-390.
28. Bauman ML БМЛ. “Autism: Multidisciplinary Evaluation and Treatment. The LADDERS Model”. Autism and Developmental Disorders 18.3 (2020): 22.
29. Hendren RL., et al. “Randomized, Placebo-Controlled Trial of Methyl B12 for Children with Autism”. Journal of Child and Adolescent Psychopharmacology 26.9 (2016): 774-783.
30. Michael Telias Dalit Ben-Yosef. “Neural stem cell replacement: a possible therapy for neurodevelopmental disorders”. Neural Regeneration Research 10.2 (2015): 180-182.
31. Cheffer A., et al. “Human stem cell-based models for studyingautism spectrum disorder-related neuronal dysfunction”. Molecular Autism 11.1 (2020): 99.
32. Gray SJ. “Gene therapy and neurodevelopmental disorders”. Neuropharmacology 68 (2013): 136-142.
33. Turner TJ., et al. “Recent advances in gene therapy for neurodevelopmental disorders with epilepsy”. Journal of Neurochemistry (2020).
34. Wu H., et al. “Deep Brain Stimulation Modified Autism-Like Deficits via the Serotonin System in a Valproic Acid-Induced Rat Model”. International Journal of Molecular Sciences 19.9
(2018): 2840.
35. Datko M., et al. “Positive effects of neurofeedback on autism symptoms correlate with brain activation during imitation and observation”. The European Journal of Neuroscience 47.6
(2018): 579-591.
36. HOLTMANN M., et al. “Neurofeedback in autism spectrum disorders”. Developmental Medicine and Child Neurology 53.11 (2011): 986-993.
37. McGuinness G and Kim Y. “Sulforaphane treatment for autism spectrum disorder: A systematic review”. (2020).
38.https://www.researchgate.net/publication/349044003_Neurodevelopmental_Disorders_The_Past_Present_and_the_Future
Abstract
Neurodevelopmental disorders are a group of complex multifactorial disorders with significant symptom overlap that arise during the developmental period. This presentation will illustrate the continuously evolving knowledge of these disorders as well as the potential growth in future directions. These disorders can not only affect individuals, but society as a whole. Accumulated knowledge of these disorders has slowly began to shift the perception of these disorders as well as help individuals experiencing these conditions feel less stigmatized by society.
As the prevelence of these disorders is on the rise, it is important that individuals are able to receive a diagnosis early on, as well as proper resources to help them navigate thier life. The inclusion of questions related to childhood development can aid clinicians screen for these disorders even in adult patients and help manage symptoms appropriately. Knowledge of NDD would help differentiate these patients presentaing with concurrent psychiatric disorders from other comorbid conditions like personality disorders and substance abuse.